Mark Messier is the founder of BioRunUp.com.  Mark is a DOJ certified Criminal Intelligence Analyst and former IT professional, specializing in law enforcement applications.  In 2008 Mark began trading biotech stocks, using his analytical expertise to detect and capitalize on human and market patterns.  Starting with only $2200 in his trading account he has managed to bank over $400k of profit in just a few short years (Profitly).  In April 2010 Mark founded the blog BioRunUp.com to share his trading ideas with the online community.  In October 2010 BioRunUp merged with Mike Havrilla's MikeHavRx.com to become the subscription website it is today. In 2012 Mark began writing a weekly biotech trading columns as a contributer to TheStreet (link). Mark enjoys spending time with his wife and two young boys and trading from his 'home away from home' in Costa Rica.  

Mike Havrilla is a clinical IV pharmacist, writer, marathon runner, and biotech stock trader with experience that includes licensed pharmacist since January 2004, online investing since August 1997 and writing for investors since April 2007. Mike holds Doctor of Pharmacy and Bachelor of Science (Biology) degrees from the University of Pittsburgh and worked in the pharmaceutical industry for Wyeth prior to pharmacy school. He is also an avid runner (50-75 miles per week) since 1992 and has completed 22 marathons with a personal best time of 2 hours, 54 minutes for the 26.2 mile race.  

Steve Johannsen is working full time as a process chemist in the biotech industry developing synthetic routes to prepare drug candidates for clinical trials and commercial use.  He discovered the run up trading strategy after his company received a CRL and watched in horror as the share price tanked.  Steve recognized the power of the run up and immediately began applying his education and pharmaceutical background to profit from the industry he is most familiar with.  Along with traditional run-up and run-down trades Steve enjoys planning option spreads with defined risk/reward and holding these through catalyst events.  Due to his schedule he is most active during the morning hours before starting his day job.  Steve has an undergraduate degree in biochemistry and holds a master’s degree in organic chemistry.  He enjoys spending his time cooking (earned a culinary arts degree for fun), skiing, mountain biking and traveling. 

Nick DeCesare is an educator, writer, and individual investor since 1996.  Nick has been researching, trading, and writing about biotech stocks since 2006. He has used his trading/investing experience to capitalize on the many opportunities the biotech trading market has to offer day in and day out.  His trading strategy focuses on staying long in one or two biotech names that offer the most upside potential while trading other biotech stocks that tend to “range trade” and provide healthy short term profits.  The key to maximizing profits in Nick’s account has always been to take some small, high percentage risks once healthy profits have been built (possibly holding through a data, an advisory panel or a PDFUA date).  Nick has a Master’s Degree in education, his administrative leadership certification and an A+ computer repair certification.  Nick currently manages and oversees all aspects of a private education facility with a budget of over 2 million dollars.  His spare time is spent with his wife and daughter and researching all aspects of biotech stocks.  Nick enjoys frequent trips to Rhode Island and Florida with his family.  

Bill Rusnak is a medical student (M.D. candidate for 2014), financial investor, writer, and want-to-be entrepreneur. In 2008, he began his development as a trader by constantly researching market theory, studying trading strategies, training himself in technical analysis, and trading a small amount of capital to become exposed to the emotional traps of the market, all while successfully maintaining a full-time student status at the Pennsylvania State University. Since 2009, he has been developing and testing his own technical trading strategies, which were specifically designed for various index futures contracts. In 2010, Bill began applying his understanding of technical analysis to biotech stocks and is now sharing his knowledge by writing articles for BioRunUp.com When not trading, writing, or studying medicine, Bill enjoys spending time with his wonderful wife, playing guitar, enjoying the outdoors, obsessing over healthy foods and activities, and ranting about random business ideas.

Adlai Pappy graduated this spring from Princeton University and currently works as a research assistant and in the Pediatric department at the University of Michigan hospital. He has been an investor since 2008 and on 2010, he joined BioRunUp after being introduced to the website by a college roommate, because he loved the idea of leveraging his molecular biology degree with financial investments in the life science industry. He utilizes BioRunUp’s great catalyst trading strategies with hedges through selling calls for smaller but consistent gains. He was a swimmer in college and loves to snowboard, lift, and to dance hip/hop.